Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Martijn B.A van Doorn"'
Publikováno v:
JAAD Case Reports, Vol 21, Iss , Pp 109-111 (2022)
Externí odkaz:
https://doaj.org/article/74090f87770146f3aae95c5251a13115
Autor:
Leonie C. Stroet, MD, Maud A.W. Hermans, MD, PhD, M. Maurer, MD, Martijn B.A. van Doorn, MD, PhD
Publikováno v:
JAAD Case Reports, Vol 19, Iss , Pp 18-20 (2022)
Externí odkaz:
https://doaj.org/article/87fbaaccce3742c08d1c41bbb77da761
Autor:
Marloes E. van Muijen, Sarah E. Thomas, Douwe Vellinga, Silke Bouwman, Martijn B.A. van Doorn, Klaziena Politiek, Marisol E. Otero, Juul M.P.A. van den Reek, Elke M.G.J. de Jong
Publikováno v:
Acta Dermato-Venereologica, Vol 102 (2022)
Abstract is missing (Short communication)
Externí odkaz:
https://doaj.org/article/f56aae0ea10b4cf7b759c218087ff36e
Autor:
Ivan Cherrez-Ojeda, Emanuel Vanegas, Annia Cherrez, Miguel Felix, Karsten Weller, Markus Magerl, Rasmus Robin Maurer, Valeria L. Mata, Alicja Kasperska-Zajac, Agnieszka Sikora, Daria Fomina, Elena Kovalkova, Kiran Godse, Nimmagadda Dheeraj Rao, Maryam Khoshkhui, Sahar Rastgoo, Roberta FJ. Criado, Mohamed Abuzakouk, Deepa Grandon, Martijn B.A. Van Doorn, Solange Oliveira Rodrigues Valle, Eduardo Magalhães De Souza Lima, Simon Francis Thomsen, German D. Ramón, Edgar E. Matos Benavides, Andrea Bauer, Ana M. Giménez-Arnau, Emek Kocatürk, Carole Guillet, Jose Ignacio Larco, Zuo-Tao Zhao, Michael Makris, Carla Ritchie, Paraskevi Xepapadaki, Luis Felipe Ensina, Sofia Cherrez, Marcus Maurer
Publikováno v:
World Allergy Organization Journal, Vol 14, Iss 6, Pp 100542- (2021)
Background: Patients with chronic urticaria (CU) are increasingly using information and communication technologies (ICTs) to manage their health. What CU patients expect from ICTs and which ICTs they prefer remains unknown. We assessed why CU patient
Externí odkaz:
https://doaj.org/article/37a907e6851b448797cb8e5cc5de537c
Publikováno v:
JAAD Case Reports, Vol 6, Iss 8, Pp 716-718 (2020)
Externí odkaz:
https://doaj.org/article/c1116148eee74d12a0968f00dcef0fdd
Autor:
Ellen H.A. van den Munckhof, Tessa Niemeyer-van der Kolk, Hein van der Wall, Dirk C.J.G. van Alewijk, Martijn B.A. van Doorn, Jacobus Burggraaf, Thomas P. Buters, Martin J. Becker, Gary L. Feiss, Wim G.V. Quint, Leen-Jan van Doorn, Cornelis W. Knetsch, Robert Rissmann
Publikováno v:
Acta Dermato-Venereologica, Vol 100, Iss 1, p adv00018 (2020)
Abstract is missing (Short communication)
Externí odkaz:
https://doaj.org/article/b969da2c154343a3aef501ba7c63994e
Autor:
Juul M.P.A. van den Reek, Lieke J. van Vugt, Martijn B.A. van Doorn, Gayle E. van der Kraaij, Wim J.A. de Kort, Georges P.H. Lucker, Barbara Horvath, M. David Njoo, H. Jorn Bovenschen, Paul M. Ossenkoppele, Marjolein S. De Bruin-Weller, Marjan de Groot, Roland Mommers, Ruud L.M.A. Prevoo, Peter C.M. van de Kerkhof, Phyllis I. Spuls, Wietske Kievit, Elke M.G.J. de Jong
Publikováno v:
Acta Dermato-Venereologica, Vol 98, Iss 7, Pp 648-654 (2018)
Interleukin 17-antagonist secukinumab demonstrated high efficacy for treatment of psoriasis in randomized controlled trials. However, performance in daily practice may differ from trials. Drug survival is a comprehensive outcome covering effectivenes
Externí odkaz:
https://doaj.org/article/b0da904a333c44fd885e51e01c2db934
Autor:
Fazira R. Kasiem, Annelieke Pasma, Jolanda J. Luime, Ilja Tchetverikov, Kim Wervers, Lindy-Anne Korswagen, Natasja Denissen, Yvonne P.M. Goekoop-Ruiterman, Maikel van Oosterhout, Faouzia Fodili, Johanna M.W. Hazes, Martijn B.A. van Doorn, Marc R. Kok, Marijn Vis
Publikováno v:
The Journal of rheumatology, 49(10), 1117-1123. Journal of Rheumatology
ObjectiveRheumatologists play a pivotal role in the management of patients with psoriatic arthritis (PsA). Due to time constraints during clinic visits, the skin may not receive the attention needed for optimal patient outcome. Therefore, the aim of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7bc88f7314b41078a5899dbe229e9c89
https://doi.org/10.3899/jrheum.210550
https://doi.org/10.3899/jrheum.210550
Autor:
Pim Aarts, Johanna C. van Huijstee, Hessel H. van der Zee, Martijn B.A. van Doorn, Kelsey R. van Straalen, Errol P. Prens
Publikováno v:
Journal of the American Academy of Dermatology. Mosby Inc.
Background: Adalimumab, the only biologic registered for hidradenitis suppurativa, shows clinical response in up to 60% of patients, leaving many patients in need for other treatment options such as surgery. Objective: To compare the clinical effecti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::daa3748b5f46c5d74547da2585ed87a3
https://pure.eur.nl/en/publications/4d474663-6a7c-4e52-bfd1-81b2039c8a90
https://pure.eur.nl/en/publications/4d474663-6a7c-4e52-bfd1-81b2039c8a90
Autor:
Helen R. Gosselt, Jette A. van Lint, Leanne J. Kosse, Phyllis I. Spuls, Harald E. Vonkeman, Sander W. Tas, Frank Hoentjen, Michael T. Nurmohamed, Bart J.F. van den Bemt, Martijn B.A. van Doorn, Naomi T. Jessurun
Publikováno v:
Expert Opinion on Drug Safety. Taylor & Francis Ltd
Gosselt, H R, van Lint, J A, Kosse, L J, Spuls, P I, Vonkeman, H E, Tas, S W, Hoentjen, F, Nurmohamed, M T, van den Bemt, B J F, van Doorn, M B A & Jessurun, N T 2023, ' Sex differences in adverse drug reactions from Adalimumab and etanercept in patients with inflammatory rheumatic diseases ', Expert opinion on drug safety . https://doi.org/10.1080/14740338.2023.2181340
Expert opinion on drug safety. Taylor & Francis
Expert opinion on drug safety. Taylor and Francis Ltd.
Gosselt, H R, van Lint, J A, Kosse, L J, Spuls, P I, Vonkeman, H E, Tas, S W, Hoentjen, F, Nurmohamed, M T, van den Bemt, B J F, van Doorn, M B A & Jessurun, N T 2023, ' Sex differences in adverse drug reactions from Adalimumab and etanercept in patients with inflammatory rheumatic diseases ', Expert opinion on drug safety . https://doi.org/10.1080/14740338.2023.2181340
Expert opinion on drug safety. Taylor & Francis
Expert opinion on drug safety. Taylor and Francis Ltd.
Background: We examine sex differences in relation to the nature, frequency, and burden of patient-reported adverse drug reactions (ADRs) in patients with inflammatory rheumatic diseases. Research design and methods: Rheumatoid arthritis, psoriatic a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc607e4de4e5ca6c882d4814677a707a
https://pure.eur.nl/en/publications/ded233d7-47b1-4304-88a5-3c9d87d47e17
https://pure.eur.nl/en/publications/ded233d7-47b1-4304-88a5-3c9d87d47e17